These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 36041358)
1. N-acetylcysteine attenuates atherosclerosis progression in aging LDL receptor deficient mice with preserved M2 macrophages and increased CD146. Zhu Q; Xiao Y; Jiang M; Liu X; Cui Y; Hao H; Flaker GC; Liu Q; Zhou S; Liu Z Atherosclerosis; 2022 Sep; 357():41-50. PubMed ID: 36041358 [TBL] [Abstract][Full Text] [Related]
2. N-acetylcysteine inhibits in vivo oxidation of native low-density lipoprotein. Cui Y; Narasimhulu CA; Liu L; Zhang Q; Liu PZ; Li X; Xiao Y; Zhang J; Hao H; Xie X; He G; Cui L; Parthasarathy S; Liu Z Sci Rep; 2015 Nov; 5():16339. PubMed ID: 26536834 [TBL] [Abstract][Full Text] [Related]
3. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice. Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917 [TBL] [Abstract][Full Text] [Related]
4. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice. Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052 [TBL] [Abstract][Full Text] [Related]
5. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice. Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215 [TBL] [Abstract][Full Text] [Related]
13. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [ Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625 [TBL] [Abstract][Full Text] [Related]
14. Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet. Ma Y; Wang W; Zhang J; Lu Y; Wu W; Yan H; Wang Y PLoS One; 2012; 7(4):e35835. PubMed ID: 22558236 [TBL] [Abstract][Full Text] [Related]
15. Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice. Zhang D; Fang P; Jiang X; Nelson J; Moore JK; Kruger WD; Berretta RM; Houser SR; Yang X; Wang H Circ Res; 2012 Jun; 111(1):37-49. PubMed ID: 22628578 [TBL] [Abstract][Full Text] [Related]
16. Disocin prevents postmenopausal atherosclerosis in ovariectomized LDLR-/- mice through a PGC-1α/ERα pathway leading to promotion of autophagy and inhibition of oxidative stress, inflammation and apoptosis. Yang Q; Wang C; Jin Y; Ma X; Xie T; Wang J; Liu K; Sun H Pharmacol Res; 2019 Oct; 148():104414. PubMed ID: 31449974 [TBL] [Abstract][Full Text] [Related]
17. Regulation of high-density lipoprotein on hematopoietic stem/progenitor cells in atherosclerosis requires scavenger receptor type BI expression. Gao M; Zhao D; Schouteden S; Sorci-Thomas MG; Van Veldhoven PP; Eggermont K; Liu G; Verfaillie CM; Feng Y Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1900-9. PubMed ID: 24969774 [TBL] [Abstract][Full Text] [Related]